The global postoperative pain therapeutics market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The increased demand for pain control drugs and devices is fueling the growth of the global postoperative pain therapeutics market. The number of surgeries for cancer patients is increasing all across the globe, therefore leading the market growth. One of the most adverse effects of postoperative results is the pain that causes physical distress, prolonged hospital stay, and increasing incidences of readmissions of patients post-surgery. For postoperative pain, single analgesics are not effective in providing active pain relief for moderate or severe pain and are also associated with side effects such as vomiting, nausea, bleeding, or sedation. 

As far as the major focus of postoperative pain treatment is concerned, they not only reduce pain intensity, however, also improve postoperative results and increase patient comfort. Postoperative pain management is the most pivotal factor of patient treatment as it aims at initiating mobilization, enhancing patient comfort, and reducing the likelihood of cardiac, pulmonary, and neuropathic pain complications reduced the risk of thrombosis and further lessening the cost of care. The postoperative pain treatment consists mainly of multimodal analgesic treatment that includes a combination of various analgesics that act by the various mechanism of action.

Some key players operating in the market include Mallinckrodt Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Pacira BioSciences, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., among others. These players are aiming at strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

• Competitive Landscape: Mallinckrodt Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Pacira BioSciences, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Postoperative Pain Therapeutics Market by Segment

By Drug Class 

• Opioids

• NSAIDs

• Local Anesthetics

• Tricyclic Antidepressants

• Antiepileptic Drugs 

• Others

By Route Of Administration 

• Oral

• Intramuscular

• Intravenous 

• Others

By Distribution Channel 

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

• Others

Global Postoperative Pain Therapeutics Market  by Region